Drug profile · INN
oxymorphone hydrochloride
OXYMORPHONE HYDROCHLORIDE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12005054
Piperidinyl-3-(aryloxy)propanamides and propanoates
granted -
US 11045457
Piperidinyl-3-(aryloxy)propanamides and propanoates
granted -
US 10968213
Cyclopropanamine compound and use thereof
granted -
US 10414761
Cyclopropanamine compound and use thereof
granted -
US 10233142
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted -
US 10053456
Cyclopropanamine compound and use thereof
granted -
US 9920047
Cyclopropanamine compound and use thereof
granted -
US 9850199
Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
granted
Frequently asked questions
What is oxymorphone hydrochloride?
oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for oxymorphone hydrochloride?
OXYMORPHONE HYDROCHLORIDE is a marketed brand name for oxymorphone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oxymorphone hydrochloride?
oxymorphone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.